Document -
Olink Bioscience introduces a new 92-protein biomarker panel for oncology research
Uppsala, Sweden, December 2, 2015 - Olink Bioscience today launched Proseek® Multiplex Oncology II96x96 a new human protein biomarker panel that targets the cancer research area. With the launch of this new panel, Olink can now provide more than 350 unique protein biomarker assays. This offering will be significantly expanded in early 2016 with a panel focused on the field of neurology.
-
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: .pdf
